Lanthanum carbonate 250 mg Chewable Tablet
RxNorm 477343
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 477343 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: lanthanum carbonate 250 mg Chewable Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCD
Semantic Clinical Drug (SCD):
Lanthanum carbonate 250 mg Chewable Tablet
(Atom ID: 2182260)
PT
Designated preferred name (PT):
Lanthanum (as lanthanum carbonate) 250 mg chewable tablet
(Atom ID: 12665231)
PSN
Prescribable Name (PSN):
Lanthanum carbonate 250 mg Chewable Tablet
(Atom ID: 6359344)
FN
Full form of descriptor (FN):
Product containing precisely lanthanum (as lanthanum carbonate) 250 mg/1 each conventional release chewable tablet (clinical drug)
(Atom ID: 12665986)
Patient Education
Lanthanum
Lanthanum is used to reduce blood levels of phosphate in people with kidney disease. High levels of phosphate in the blood can cause bone problems. Lanthanum is in a clsas of medications called phosphate binders. It binds phosphorus that you get from foods in your diet and prevents it from being absorbed into your blood stream.
[Learn More]
* Please review the disclaimer below.